Comment
Scott Boyes, CEO of the MPX Bioceutical Corporation (CSE:MPX; OTC:MPXEF) told the Investing News Network (INN) that concern about Sessions had left his mind.
MPX also suffered a dip in its shares following the report on the Attorney General. At 12:02 p.m. EST, on the Canadian Securities Exchange stock had gone down 16 percent, while its U.S. counterpart had decreased 15.56 percent.
“Everybody asks you ‘aren’t you worried about Trump and Sessions shutting the industry down?’ Most people in the industry went way past that a long time ago,” Boyes told INN, at the time arguing the potential revenue of this industry would be enough to change the mind of Trump and Sessions.
Update from market closure
After the initial downfall on the markets Thursday morning, the drop eased up a bit for cannabis stocks and its exchange-traded fund (ETF).